| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Overview of Adjuvant Systemic Chemotherapy for Colon Cancer
|
André, Thierry
|
|
2004
|
|
S1 |
p. S22-S28
7 p.
|
artikel
|
| 2 |
An Overview of Approaches to Adjuvant Therapy for Colorectal Cancer in the United States
|
Hobday, Timothy J.
|
|
2005
|
|
S1 |
p. S11-S18
8 p.
|
artikel
|
| 3 |
Application of Pharmacogenomics in the Individualization of Chemotherapy for Gastrointestinal Malignancies
|
McLeod, Howard L.
|
|
2004
|
|
S1 |
p. S43-S47
5 p.
|
artikel
|
| 4 |
A Retrospective on the Inhibition of Epidermal Growth Factor Receptor as a Therapeutic Strategy for Patients with Relapsed Metastatic Colorectal Cancer: Impact on Treatment of Today's Patients
|
Jackson, Christopher
|
|
2007
|
|
S1 |
p. S8-S15
8 p.
|
artikel
|
| 5 |
Benefits and Drawbacks of the Use of Oral Fluoropyrimidines as Single-Agent Therapy in Advanced Colorectal Cancer
|
Cassidy, Jim
|
|
2005
|
|
S1 |
p. S47-S50
4 p.
|
artikel
|
| 6 |
Beyond Imatinib: Second Generation c-KIT Inhibitors for the Management of Gastrointestinal Stromal Tumors
|
von Mehren, Margaret
|
|
2006
|
|
S1 |
p. S30-S34
5 p.
|
artikel
|
| 7 |
Cetuximab in Previously Treated Colorectal Cancer
|
Starling, Naureen
|
|
2005
|
|
S1 |
p. S28-S33
6 p.
|
artikel
|
| 8 |
Clinical Management of Oxaliplatin-Associated Neurotoxicity
|
Grothey, Axel
|
|
2005
|
|
S1 |
p. S38-S46
9 p.
|
artikel
|
| 9 |
Combined-Modality Therapy of Rectal Cancer with Oxaliplatin-Based Regimens
|
Minsky, Bruce D.
|
|
2004
|
|
S1 |
p. S29-S36
8 p.
|
artikel
|
| 10 |
Combining Imatinib with Surgery in Gastrointestinal Stromal Tumors: Rationale and Ongoing Trials
|
Eisenberg, Burton L.
|
|
2006
|
|
S1 |
p. S24-S29
6 p.
|
artikel
|
| 11 |
Current Approaches to First-Line Treatment of Advanced Colorectal Cancer
|
Rothenberg, Mace L.
|
|
2004
|
|
S1 |
p. S16-S21
6 p.
|
artikel
|
| 12 |
Current Approaches to First-Line Treatment of Advanced Colorectal Cancer
|
Goldberg, Richard M.
|
|
2004
|
|
S1 |
p. S9-S15
7 p.
|
artikel
|
| 13 |
Emerging Perspectives in the Management of Colorectal Cancer
|
Haller, Daniel G.
|
|
2004
|
|
S1 |
p. S7-
1 p.
|
artikel
|
| 14 |
Emerging Trends in the Management of Colorectal Cancer
|
Chu, Edward
|
|
2005
|
|
S1 |
p. S10-
1 p.
|
artikel
|
| 15 |
Epidermal Growth Factor Receptor as a Target for Chemotherapy
|
Vallböhmer, Daniel
|
|
2005
|
|
S1 |
p. S19-S27
9 p.
|
artikel
|
| 16 |
Exploring Alternative Individualized Treatment Strategies in Colorectal Cancer
|
Wilson, Peter M.
|
|
2007
|
|
S1 |
p. S28-S36
9 p.
|
artikel
|
| 17 |
Irinotecan-Based Regimens in the Adjuvant Therapy of Colorectal Cancer
|
Douillard, Jean-Yves
|
|
2005
|
|
S1 |
p. S34-S37
4 p.
|
artikel
|
| 18 |
Oxaliplatin plus Oral Fluoropyrimidines in Colorectal Cancer
|
Grothey, Axel
|
|
2004
|
|
S1 |
p. S37-S42
6 p.
|
artikel
|
| 19 |
Practical Aspects of Managing Gastrointestinal Stromal Tumors
|
Sleijfer, Stefan
|
|
2006
|
|
S1 |
p. S18-S23
6 p.
|
artikel
|
| 20 |
Targeting the Right Target: Epidermal Growth Factor Receptor–Directed Individualized Therapy
|
Grothey, Axel
|
|
2007
|
|
S1 |
p. S6-S7
2 p.
|
artikel
|
| 21 |
The Molecular Pathogenesis of Gastrointestinal Stromal Tumors
|
Tarn, Chi
|
|
2006
|
|
S1 |
p. S7-S17
11 p.
|
artikel
|
| 22 |
Update on Clinical Data Combining Capecitabine with Targeted Agents in Newly Diagnosed Colorectal Cancer
|
Lee, James J.
|
|
2007
|
|
S1 |
p. S16-S20
5 p.
|
artikel
|
| 23 |
Update on Clinical Data with Regimens Inhibiting Angiogenesis and Epidermal Growth Factor Receptor for Patients with Newly Diagnosed Metastatic Colorectal Cancer
|
Cohen, Deirdre J.
|
|
2007
|
|
S1 |
p. S21-S27
7 p.
|
artikel
|
| 24 |
Update on the Management of Gastrointestinal Stromal Tumors
|
von Mehren, Margaret
|
|
2006
|
|
S1 |
p. S6-
1 p.
|
artikel
|
Tijdschrift beschrijving